Effects of pregnancy and progestational agents on the urinary tract.
D000230:Adenocarcinoma / Q000188:drug therapy; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004715:Endometriosis / Q000188:drug therapy; D005260:Female; D006801:Humans; D006869:Hydronephrosis / Q000000981:diagnostic imaging / Q000209:etiology*; D006908:Hydroxyprogesterones / Q000627:therapeutic use; D008365:Manometry; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008656:Mestranol / Q000627:therapeutic use; D009119:Muscle Contraction; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011247:Pregnancy; D011248:Pregnancy Complications / Q000000981:diagnostic imaging / Q000503:physiopathology; D011372:Progestins / Q000494:pharmacology*; D014515:Ureteral Diseases / Q000000981:diagnostic imaging / Q000209:etiology; D014551:Urinary Tract / Q000187:drug effects*; D014567:Urography; D014570:Urologic Diseases / Q000209:etiology*
D006908:Hydroxyprogesterones; D011372:Progestins; D004054:Diethylstilbestrol; D008656:Mestranol; D008525:Medroxyprogesterone